Introducción: La rehabilitación pulmonar (RP) es una intervención que disminuye los síntomas de la Enfermedad Pulmonar Obstructiva Crónica (EPOC), incrementa la tolerancia al ejercicio, el estado emocional, la funcionalidad, la participación y la percepción de control de la enfermedad, mejorando la calidad de vida. Objetivo: Describir los efectos de la RP sobre dos escalas de calidad de vida y su influencia en la capacidad aeróbica funcional en pacientes con EPOC. Materiales y métodos: Estudio cuasiexperimental en pacientes que asistieron a RP. La capacidad aeróbica funcional se evaluó con el test de caminata de 6 minutos y la calidad de vida relacionada con la salud con los cuestionarios St. George Respiratory Questionnaire (SGRQ) y Chronic Respiratory Disease Questionnaire (CRQ-SAS). Resultados: Diferencias significativas en test de caminata de 6 minutos 51.9±44.5 metros; p<0.001. El SGRQ en actividad (inicial:65.9±16.8 y final 50.8±19.5; p<0.001), síntomas (inicial 45±17.9; final 33.6±16.8; p=0.005), impacto (inicial 40.5±16.4; final 31.8±18.1; p=0.004) y total (inicial 49.8±14.8; final 40.7±17.7; p=0.002). El CRQ-SAS en disnea (inicial 3.8±1.3; final 4.7±1.1; p<0.001), emocional (inicial 5.1±1 final 5.7±0.9; p<0.001) y total (inicial 4.6±0.9 final 5.3±0.8; p<0.001). Conclusiones: La RP favorece la calidad de vida evaluada con el SGRQ y el CRQ-SAS y la capacidad aeróbica funcional de los pacientes con EPOC.
14 January 2020 in Current Respiratory Medicine Reviews
Objective: To determine the effects of a pulmonary rehabilitation program in patients with COPD who use and do not use supplemental oxygen during exercise.Materials and Methods: Prospective longitudinal descriptive study on 59 patients with COPD who were part of a pulmonary rehabilitation program and who were classified into two groups: a group that required supplemental oxygen during rehabilitation and another that did not.Results: 31 patients were linked to the group that used oxygen during rehabilitation and 28 patients who did not use it. The average age was 69.1 ± 10.6 years old. The mMRC dyspnea decreased 0.7 ± 0.2 (p = 0.000) in the group that used oxygen and 0.8 ± 0.1 (p = 0.000) in the group that did not use it. The distance increased 45.9 meters ± 7.2 (p = 0.000) in the group that used oxygen and 65.2 meters ± 16.3 (p = 0.001) in the group that did not use it.Conclusion: Both groups showed significant improvements in dyspnea and aerobic capacity, however, there was a greater increase in the group that did not use oxygen.
1 January 2021 in Journal of Human Sport and Exercise